These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 22572996)
21. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298 [TBL] [Abstract][Full Text] [Related]
22. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
23. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168 [TBL] [Abstract][Full Text] [Related]
24. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome]. Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950 [TBL] [Abstract][Full Text] [Related]
25. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528 [TBL] [Abstract][Full Text] [Related]
26. Glucose intolerance in Japanese patients with polycystic ovary syndrome. Kurioka H; Takahashi K; Miyazaki K Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071 [TBL] [Abstract][Full Text] [Related]
27. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004 [TBL] [Abstract][Full Text] [Related]
28. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564 [TBL] [Abstract][Full Text] [Related]
29. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome. Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799 [TBL] [Abstract][Full Text] [Related]
30. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152 [TBL] [Abstract][Full Text] [Related]
31. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study. Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin. Sun X; Wu X; Zhou Y; Yu X; Zhang W Med Sci Monit; 2015 Aug; 21():2547-52. PubMed ID: 26314870 [TBL] [Abstract][Full Text] [Related]
33. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
34. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases]. Song J; Shen H; Li J; Huang Z; Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923 [TBL] [Abstract][Full Text] [Related]
36. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
37. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
38. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]. Hu WH; Qiao J; Li MZ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization. Kumbak B; Kahraman S Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135 [TBL] [Abstract][Full Text] [Related]
40. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance]. Wan DH; Fan P; Bai H; Song Q; Liu HW Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]